Protein A resin is a medium used for the purification of antibodies through affinity chromatography. Antibodies are the primary targets for affinity chromatography as they have specific regions of interaction with Protein A. Protein A is an Fc-binding bacterial protein isolated from Staphylococcus aureus. It selectively binds to the Fc region of antibodies of human and certain other species origin and allows for the effective purification of antibodies in a single step. Monoclonal antibodies form the backbone of biotherapeutics research currently. With increasing investments in developing novel therapeutics based on monoclonal antibodies, the demand for Protein A resins is consistently rising to enable large-scale downstream processing of these molecules.

Market Dynamics:

The global Protein A resin market is driven by the exponential growth of the biopharmaceutical industry and associated rise in the demand for monoclonal antibody therapeutics. The availability of technologically-advanced Protein A resins that allow efficient, high yield, and selective purification of antibodies is also propelling the market growth. However, high costs associated with Protein A media and lack of standardization in regeneration and sanitization protocols are hindering the market growth to an extent. The development of novel regenerated Protein A resins that enable multiple regeneration cycles without loss of binding capacity opens lucrative opportunities for manufacturers.

Key Features of the Study:

• This report provides in-depth analysis of the global Protein A resin market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Protein A resin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Repligen Corporation, Thermo Fischer Scientific Inc., GenScript, Expedeon Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Protein A resin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Protein A resin market

Detailed Segmentation-

• By Product
  
  • Natural Protein A
  • Recombinant Protein A
    
• By Matrix Type
  
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
•  By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
•  By End User
  • Biopharmaceutical Companies
  • Clinical Research Laboratories
  • Academic Institutes
• By Region:         
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GE Healthcare
  • Merck Millipore
  • Thermo Fisher Scientific
  • Tosoh Bioscience
  • Repligen
  • Purolite
  • Agarose Bead Technologies
  • Bio-Rad Laboratories
  • GenScript
  • PerkinElmer
  • Takara Bio
  • Expedeon
  • Novasep
  • JSR Life Sciences
  • Kaneka Corporation
  • R. Grace & Co.
  • Prometic Life Sciences
  • Orochem Technologies